AKT1 and schizophrenia: It has been reported that AKT1 gene polymorphisms are associated with schizophrenia (Xu et al., 2007), and antipsychotic drugs modulate the Akt/GSK-3 and Wnt signaling pathways in order to correct the deficits induced by the gene mutation (Alimohamad et al., 2005b).